CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 12 enrolled
Drug / intervention
Aventis U-400 Insulindevice
Likely dose
Aventis U-400 Insulin (dose not specified)AI-extracted
Key inclusion· 1
  • ✓Prior implantation with MiniMed Implantable Pump model 2000 at Johns Hopkins
Key exclusion· 1
  • ✕Not previously implanted with MiniMed Implantable Pump model 2000 at Johns Hopkins

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00298740
NCT00298740N/ACompleted
CompareCT.gov

Reimplantation of Subjects With Implantable Insulin Pump Therapy

Johns Hopkins University·interventional·Posted Mar 3, 2006·Updated Sep 12, 2017

In Brief

A clinical study evaluating Aventis U-400 Insulin for Type 1 Diabetes. Completed, enrolled 12 participants across 1 site.

Detailed Summary

This research is being done to find out whether subjects previously treated with the implantable insulin pump (IIP) therapy, and now taking insulin by injection, will benefit from re-implantation of IIP. The investigators will see if IIP causes more stable control of blood sugar, with fewer highs and lows. People with type 1 diabetes previously implanted with the MiniMed Implantable Pump (MIP) model 2000 at Johns Hopkins may join this study.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsType 1 Diabetes
CountriesUnited States
CollaboratorsNational Institutes of Health (NIH), Medtronic

Timeline

N/ACompletedFinished
2003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedMar 3, 2006
Enrollment StartFeb 1, 2003
Primary CompletionSep 24, 2009
TodayJul 2, 2026
Enrollment to primary: 6.6 yearsPosted 20.3 years ago

Interventions

Aventis U-400 Insulindevice